IP Library Granted Patent US 12,642,782
Granted Patent B2
US 12,642,782 · App. 18/372,724 · Granted Jun 2, 2026

Ketogenic compositions and methods of use thereof

Inventor: Franco Cavaleri (Surrey, CA)
A61K31/216A61K9/0053A61K9/48A61K31/135A61K31/198A61K36/28A61K36/77A61K36/82A61K36/84A61P3/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,642,782
App. No.
18/372,724
Granted
Jun 2, 2026
Kind
B2
Abstract

Compositions and methods for providing a person with an exogenous and therapeutically effective supply of short chain fatty acids, chlorogenic acid, and, optionally, ketones are disclosed. The compositions include one or more short chain fatty acids (such as butyric acid, butyrate salts, propionic acid, propionate salts, acetic acid, or acetate salts); chlorogenic acid; and, optionally, one or more beta-hydroxybutyrate salts. The compositions and methods are useful for inducing ketosis and/or beta-oxidative activity in a subject. In addition, compositions that include concentrated forms of, and methods of using, chlorogenic acid (alone or in combination with short chain fatty acids and ketones) to induce ketogenesis in a subject are disclosed.

Claims (7)

1 . A composition consisting essentially of:

(a) chlorogenic acid;

(b) one or more butyrate salts selected from the group consisting of butyrate sodium salt, butyrate calcium salt, and butyrate magnesium salt, wherein the composition is packaged as an oral capsule or in powdered form, wherein the composition is effective to deliver via oral administration at least 50 mg of chlorogenic acid and at least 50 mg of the one or more butyrate salts to a person; and

(c) one or more agents selected from the group consisting of potassium citrate, magnesium citrate, green tea extract, guarana extract, L-theanine, phenethylamine, L-tryptophan, valerian root extract, chamomile flower extract, passion fruit extract, ferulic acid, octacosanol, and one or more vitamins.

2 . The composition of claim 1 , wherein the composition includes:

(a) 100-500 mg of chlorogenic acid; and

(b) 50-250 mg of butyrate calcium salt.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2023
From: CAVALERI, FRANCO
To: CAVALERI HEALTH, INC.
Reel/Frame 065023/0559 →
Continuity (2)
Provisional Application 63420723 · Oct 31, 2022
Related Publication 20240156771A1 · May 16, 2024
References Cited (9)
US 20170042842A1 · Edge · 2017 [cited by examiner]
US 20170290792A1 · Cavaleri · 2017 [cited by examiner]
WO WO2018020512A1 · 2018 [cited by examiner]
WO WO2020086820A1 · 2020 [cited by examiner]
Bachmann et al., “Traditional Foods as Alternatives to Synthetic Compounds” Agroscope Sep. 18, 2020 pp. 1-4. (Year: 2020). [cited by examiner]
Devappa et al., “Forest biorefinery: Potential of poplar phytochemicals as value-added co-products” Biotechnology Advances 33 (2015) 681-716. (Year: 2015). [cited by examiner]
Gurley et al., “Multi-ingredient, caffeine-containing Dietary Supplements: History, Safety, and Efficacy” Clinical Therapeutics/vol. 37, No. 2, 2015, pp. 275-301. (Year: 2015). [cited by examiner]
Head et al., “Nutrients and Botanicals for Treatment of Stress: Adrenal Fatigue, Neurotransmitter Imbalance, Anxiety, and Restless Sleep” Alternative Medicine Review, vol. 14, No. 2, 2009, pp. 114-140. (Year: 2009). [cited by examiner]
Wang et al., “Chlorogenic acid alleviates obesity and modulates gut microbiota in high-fat-fed mice” Food Sci Nutr. 2019; 7: 579-588. (Year: 2019). [cited by examiner]